EMCURE PHARMACEUTICALS
Back to Cashflow Statement
|
EMCURE PHARMACEUTICALS Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹852 Cr | ₹1,097 Cr | ₹747 Cr | ₹768 Cr | ₹704 Cr |
What is the latest Cash Flow from Operating Activities ratio of EMCURE PHARMACEUTICALS ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹852 Cr |
| Mar2024 | ₹1,097 Cr |
| Mar2023 | ₹747 Cr |
| Mar2022 | ₹768 Cr |
| Mar2021 | ₹704 Cr |
How is Cash Flow from Operating Activities of EMCURE PHARMACEUTICALS Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹852 Cr | -22.38 | |
| Mar2024 | ₹1,097 Cr | 46.92 | |
| Mar2023 | ₹747 Cr | -2.78 | |
| Mar2022 | ₹768 Cr | 9.05 | |
| Mar2021 | ₹704 Cr | - | |
Compare Cash Flow from Operating Activities of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹34,415.4 Cr | -2.2% | 5.5% | 43.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹452,982.0 Cr | 0.9% | 5.6% | 14.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,361.0 Cr | 1.2% | 3.7% | -1.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹164,737.0 Cr | 4.4% | 10.3% | 42.1% | Stock Analytics | |
| CIPLA | ₹115,655.0 Cr | -1.7% | 3.1% | -4.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,573.0 Cr | 0.2% | 5.7% | 6% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | -2.2% |
5.5% |
43.8% |
| SENSEX | -0.5% |
3% |
-8.5% |
You may also like the below Video Courses